UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Pancreatology : official journal of the International Association of Pancreatology (IAP) ... [et al.], 2018-01, Vol.18 (1), p.2-11

2018

Volltextzugriff (PDF)

Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study

Journal of physical activity & health, 2019-12, Vol.16 (12), p.1113-1122

2019

Volltextzugriff (PDF)

Response to Preoperative Therapy in Localized Pancreatic Cancer

Frontiers in oncology, 2020-04, Vol.10, p.516-516

2020

Volltextzugriff (PDF)

Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis

Cancers, 2020-07, Vol.12 (8), p.2033

2020

Volltextzugriff (PDF)

Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Cancers, 2023-08, Vol.15 (16), p.4174

2023

Volltextzugriff (PDF)

Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma

JAMA surgery, 2017-11, Vol.152 (11), p.1086

2017

Volltextzugriff (PDF)

The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment

Integrative cancer therapies, 2021, Vol.20, p.1534735420986615-1534735420986615

2021

Volltextzugriff (PDF)

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

Cancers, 2023-06, Vol.15 (12), p.3231

2023

Volltextzugriff (PDF)

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy

Cancers, 2023-05, Vol.15 (9), p.2608

2023

Volltextzugriff (PDF)

Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection

The American journal of surgery, 2020-07, Vol.220 (1), p.140-146

2020

Volltextzugriff (PDF)

Selective Not Routine Use

International journal of radiation oncology, biology, physics, 2023-07, Vol.116 (4), p.707-707

Katz, Matthew H.G.

2023

Volltextzugriff (PDF)

Response to: Comment on "Effects of a Pragmatic Home-Based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial"

Annals of surgery open, 2024-06, Vol.5 (2), p.e435-e435

2024

Volltextzugriff (PDF)

Natural history and prognostic factors for localised small bowel adenocarcinoma

ESMO open, 2020-11, Vol.5 (6), p.e000960-e000960, Article e000960

2020

Volltextzugriff (PDF)

Commentary: Periadventitial dissection of the superior mesenteric artery at pancreatoduodenectomy for locally advanced pancreatic cancer

Surgery, 2021-05, Vol.169 (5), p.1034-1035

Katz, Matthew H.G.

2021

Volltextzugriff (PDF)

High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection

Cancers, 2020-10, Vol.12 (10), p.2871

2020

Volltextzugriff (PDF)

Evaluation of the reporting quality of clinical practice guidelines on pancreatic cancer using the RIGHT checklist

Annals of translational medicine, 2021-07, Vol.9 (13), p.1088-1088

2021

Volltextzugriff (PDF)

Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis

Pancreas, 2019-02, Vol.48 (2), p.216-222

2019

Volltextzugriff (PDF)

Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study

British journal of surgery, 2024-03, Vol.111 (3)

2024

Volltextzugriff (PDF)

Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy

Surgery, 2018-09, Vol.164 (3), p.424-431

2018

Volltextzugriff (PDF)

A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer

Cancers, 2020-12, Vol.12 (12), p.3635

2020

Volltextzugriff (PDF)

A Call for Caution in Overinterpreting Exceptional Outcomes After Radical Surgery for Pancreatic Cancer: Let the Data Speak

Annals of surgery, 2021-07, Vol.274 (1), p.e82-e84

2021

Volltextzugriff (PDF)

Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer

Annals of surgery, 2024-03

2024

Volltextzugriff (PDF)

NORPACT-1: implications for future trials

The lancet. Gastroenterology & hepatology, 2024-05, Vol.9 (5), p.408-408

2024

Volltextzugriff (PDF)

Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma

The oncologist (Dayton, Ohio), 2024-07

2024

Volltextzugriff (PDF)

Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study

Journal of surgical oncology, 2024-07, Vol.130 (1), p.117-124

2024

Volltextzugriff (PDF)

1 – 25 von 183

Suche als RSS-Feed

Aktive Filter

KollektionMEDLINE

ThemaMedicine & Public Health

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(143)
Mit Volltextzugriff
(149)

Publikationsform

Sprache

Englisch
(180)
Japanisch
(3)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(4)
... seit 90 Tagen
(7)

Menü

Weitere Dienste

Einstellungen

International consensus on definition and criteria of borderline resectable pancreatic ductal adenocarcinoma 2017

Supports and Barriers to Home-Based Physical Activity During Preoperative Treatment of Pancreatic Cancer: A Mixed-Methods Study

Response to Preoperative Therapy in Localized Pancreatic Cancer

Transcriptomic Profile of Lymphovascular Invasion, a Known Risk Factor of Pancreatic Ductal Adenocarcinoma Metastasis

Surgical Considerations for Neoadjuvant Therapy for Pancreatic Adenocarcinoma

Clinical and Genetic Implications of DNA Mismatch Repair Deficiency in Patients With Pancreatic Ductal Adenocarcinoma

The Role of Home-Based Exercise in Maintaining Skeletal Muscle During Preoperative Pancreatic Cancer Treatment

Comparative Analyses of the Clinicopathologic Features of Short-Term and Long-Term Survivors of Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant Therapy and Pancreatoduodenectomy

Prognosticators for Patients with Pancreatic Ductal Adenocarcinoma Who Received Neoadjuvant FOLFIRINOX or Gemcitabine/Nab-Paclitaxel Therapy and Pancreatectomy

Postoperative pancreatic fistula after distal pancreatectomy for non-pancreas retroperitoneal tumor resection

Selective Not Routine Use

Response to: Comment on "Effects of a Pragmatic Home-Based Exercise Program Concurrent With Neoadjuvant Therapy on Physical Function of Patients With Pancreatic Cancer: The PancFit Randomized Clinical Trial"

Natural history and prognostic factors for localised small bowel adenocarcinoma

Commentary: Periadventitial dissection of the superior mesenteric artery at pancreatoduodenectomy for locally advanced pancreatic cancer

High G2M Pathway Score Pancreatic Cancer is Associated with Worse Survival, Particularly after Margin-Positive (R1 or R2) Resection

Evaluation of the reporting quality of clinical practice guidelines on pancreatic cancer using the RIGHT checklist

Chemotherapy Versus Chemoradiation as Preoperative Therapy for Resectable Pancreatic Ductal Adenocarcinoma: A Propensity Score Adjusted Analysis

Impact of a non-therapeutic laparotomy in patients with locally advanced pancreatic cancer treated with induction (m)FOLFIRINOX: Trans-Atlantic Pancreatic Surgery (TAPS) Consortium study

Risk-stratified clinical pathways decrease the duration of hospitalization and costs of perioperative care after pancreatectomy

A Novel Four-Gene Score to Predict Pathologically Complete (R0) Resection and Survival in Pancreatic Cancer

A Call for Caution in Overinterpreting Exceptional Outcomes After Radical Surgery for Pancreatic Cancer: Let the Data Speak

Trends Over Time in Recurrence Patterns and Survival Outcomes after Neoadjuvant Therapy and Surgery for Pancreatic Cancer

NORPACT-1: implications for future trials

Clinical and molecular characteristics of patients with brain metastasis secondary to pancreatic ductal adenocarcinoma

Patient‐reported outcome measures in surgical patients with upper gastrointestinal cancers: A qualitative interview study

Aktive Filter

Suchergebnisse filtern